NVZMF.US Novozymes A/S B

Basic Materials Chemicals USA Stocks
77.03 USD
Close of Nov 15, 2026
50.73 73.07
Market cap
USD 31.8B
P/E
40.1x
P/B
2.55x
ROE
6.6%
Dividend yield
1.50%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is NVZMF.US undervalued?

Graham number
Price77.03
Graham value36.11
Premium113.3%

NVZMF.US trades 113.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Novozymes A/S B fundamental analysis

No fundamental analysis for Novozymes A/S B yet.

Novozymes A/S B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Novozymes A/S B

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricult…

Full company profile